Home LiteratureArticle Details
PMID: 9056006 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Mutations associated with pyrazinamide resistance in pncA of Mycobacterium tuberculosis complex organisms.

Antimicrobial agents and chemotherapy ·Vol. 41 ·No. 3 ·1997-03-00 ·Pages 636-40

Sreevatsan S, Pan X, Zhang Y, Kreiswirth BN, Musser JM

Abstract

A gene (pncA) with mutations associated with pyrazinamide resistance in Mycobacterium tuberculosis complex members was characterized in 67 pyrazinamide-resistant and 51 pyrazinamide-susceptible isolates recovered from diverse geographic localities and anatomic sites and typed by IS6110 profiling. All pyrazinamide-susceptible organisms had identical pncA alleles. In striking contrast, 72% of the 67 resistant organisms had pncA mutations that altered the primary amino acid sequence of pyrazinamidase. A total of 17 previously undescribed mutations were found, including upstream mutations, missense changes, nucleotide insertions and deletions, and termination mutations. The mutations were arrayed along virtually the entire length of the gene. These data are further evidence that most drug resistance in M. tuberculosis is due to simple mutations occurring in chromosomally encoded genes rather than to acquisition of resistance genes by horizontal transfer events.

MeSH Terms
Amidohydrolases/genetics Antitubercular Agents/pharmacology Chromosomes, Bacterial DNA, Bacterial/analysis Drug Resistance, Microbial Genes, Bacterial/genetics Humans Molecular Sequence Data Mutation Mycobacterium tuberculosis/drug effects,genetics Pyrazinamide/pharmacology Sequence Analysis, DNA Tuberculosis, Pulmonary/microbiology
Chemicals
Antitubercular Agents DNA, Bacterial Pyrazinamide Amidohydrolases pyrazinamide deamidase
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sreevatsan S
Department of Pathology, Baylor College of Medicine, Houston, Texas 77030, USA.
Pan X
Zhang Y
Kreiswirth B N
Musser J M
References (28)
28 references, click to expand
  1. Antimicrobial agent resistance in mycobacteria: molecular genetic insights.
    Clin Microbiol Rev. 1995 Oct;8(4):496-514 PMID: 8665467
  2. Activity of n-propyl pyrazinoate against pyrazinamide-resistant Mycobacterium tuberculosis: investigations into mechanism of action of and mechanism of resistance to pyrazinamide.
    Antimicrob Agents Chemother. 1995 Jun;39(6):1269-71 PMID: 7574514
  3. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family.
    JAMA. 1996 Feb 14;275(6):452-7 PMID: 8627966
  4. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antituberculous drug pyrazinamide in tubercle bacillus.
    Nat Med. 1996 Jun;2(6):662-7 PMID: 8640557
  5. Relationship between rifampin MICs for and rpoB mutations of Mycobacterium tuberculosis strains isolated in Japan.
    Antimicrob Agents Chemother. 1996 Apr;40(4):1053-6 PMID: 8849230
  6. Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City.
    Antimicrob Agents Chemother. 1996 May;40(5):1186-8 PMID: 8723463
  7. Identification of a polymorphic nucleotide in oxyR specific for Mycobacterium bovis.
    J Clin Microbiol. 1996 Aug;34(8):2007-10 PMID: 8818900
  8. Fluoroquinolone resistance associated with specific gyrase mutations in clinical isolates of multidrug-resistant Mycobacterium tuberculosis.
    J Infect Dis. 1996 Nov;174(5):1127-30 PMID: 8896523
  9. Comparative antimycobacterial activities of rifampin, rifapentine, and KRM-1648 against a collection of rifampin-resistant Mycobacterium tuberculosis isolates with known rpoB mutations.
    Antimicrob Agents Chemother. 1996 Nov;40(11):2655-7 PMID: 8913484
  10. Pyrazinamide (aldinamide) in the treatment of pulmonary tuberculosis.
    Am Rev Tuberc. 1952 May;65(5):523-46 PMID: 14924175
  11. Pyrazinamide susceptibility and amidase activity of tubercle bacilli.
    Am Rev Respir Dis. 1967 Mar;95(3):461-9 PMID: 4225184
  12. Observations in vitro on the suitability of pyrazinamide for intermittent chemotherapy of tuberculosis.
    Tubercle. 1970 Dec;51(4):389-96 PMID: 4992755
  13. Simple pyrazinamidase and urease tests for routine identification of mycobacteria.
    Am Rev Respir Dis. 1974 Jan;109(1):147-51 PMID: 4203284
  14. Improved method for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide.
    J Clin Microbiol. 1982 Dec;16(6):1106-9 PMID: 6819309
  15. The action of antituberculosis drugs in short-course chemotherapy.
    Tubercle. 1985 Sep;66(3):219-25 PMID: 3931319
  16. Slipped-strand mispairing: a major mechanism for DNA sequence evolution.
    Mol Biol Evol. 1987 May;4(3):203-21 PMID: 3328815
  17. Determination of pyrazinamide MICs for Mycobacterium tuberculosis at different pHs by the radiometric method.
    Antimicrob Agents Chemother. 1988 Jul;32(7):1002-4 PMID: 3142340
  18. Phase variation of gonococcal protein II: regulation of gene expression by slipped-strand mispairing of a repetitive DNA sequence.
    Cell. 1989 Feb 24;56(4):539-47 PMID: 2492905
  19. Amplification of a species-specific DNA fragment of Mycobacterium tuberculosis and its possible use in diagnosis.
    J Clin Microbiol. 1991 Oct;29(10):2163-8 PMID: 1939567
  20. Pyrazinamide sterilizing activity in vitro against semidormant Mycobacterium tuberculosis bacterial populations.
    Am Rev Respir Dis. 1992 May;145(5):1223-5 PMID: 1586071
  21. Strain identification of Mycobacterium tuberculosis by DNA fingerprinting: recommendations for a standardized methodology.
    J Clin Microbiol. 1993 Feb;31(2):406-9 PMID: 8381814
  22. Characterization by automated DNA sequencing of mutations in the gene (rpoB) encoding the RNA polymerase beta subunit in rifampin-resistant Mycobacterium tuberculosis strains from New York City and Texas.
    J Clin Microbiol. 1994 Apr;32(4):1095-8 PMID: 8027320
  23. Is Mycobacterium tuberculosis 15,000 years old?
    J Infect Dis. 1994 Nov;170(5):1348-9 PMID: 7963745
  24. Rapid Mycobacterium species assignment and unambiguous identification of mutations associated with antimicrobial resistance in Mycobacterium tuberculosis by automated DNA sequencing.
    Arch Pathol Lab Med. 1995 Feb;119(2):131-8 PMID: 7848059
  25. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease.
    Infect Immun. 1995 Mar;63(3):994-1003 PMID: 7868273
  26. Drug-resistant tuberculosis: inconsistent results of pyrazinamide susceptibility testing.
    JAMA. 1995 Mar 22-29;273(12):916-7 PMID: 7884943
  27. Mutation position and type of substitution in the beta-subunit of the RNA polymerase influence in-vitro activity of rifamycins in rifampicin-resistant Mycobacterium tuberculosis.
    J Antimicrob Chemother. 1995 Feb;35(2):345-8 PMID: 7759399
  28. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and -susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance.
    J Infect Dis. 1996 Jan;173(1):196-202 PMID: 8537659
Article Info
Journal
Antimicrobial agents and chemotherapy
Abbr.
Antimicrob Agents Chemother
ISSN
0066-4804
Published
1997-03-00
Pages
636-40
Language
English
Region
United States
NLM ID
0315061
PMCID
PMC163764
Subset
IM
Grants
NIAID NIH HHS · AI-37004 · United States
Databases
GENBANK
U59967
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com